Molecules 2015, 20
14590
3.6. Cyclisation Reactions of 3,4,4,5-Tetrachloro-4H-1,2,6-thiadiazine (1)
3.6.1. Synthesis of 4-Chlorobenzo[5,6][1,4]oxazino[2,3-c][1,2,6]thiadiazine (18) (General Procedure)
To a cold (0 °C) stirred solution of tetrachlorothiadiazine 1 (238 mg, 1.00 mmol) in dry MeCN
(5 mL) was added in one portion 2-aminophenol (436 mg, 4.00 mmol). The cooling bath was then removed
and the solution stirred at ca. 20 °C protected with a CaCl2 drying tube until complete consumption of
the starting material (TLC, 1 h). The mixture was then adsorbed onto silica, and chromatography
(n-hexane/DCM, 50:50) gave the title compound 18 (179 mg, 76%) as orange prisms, mp 157–160 °C
(from EtOH, lit. [16] 158–163 °C); Rf 0.43 (n-hexane/DCM, 50:50); νmax/cm−1 3103w and 3048w (Ar
CH), 1614m, 1587m, 1547m, 1518m, 1456s, 1365m, 1331s, 1308m, 1294w, 1283m, 1244m, 1206m,
1184m, 1107m, 1059m, 1026m, 978m, 968m, 945m, 901s, 876s, 868m, 800s, 763s, 748s; δH (500 MHz;
DMSO-d6) 7.24 (1H, dd, J = 7.7, 1.4, Ar H), 7.18 (1H, ddd, J = 7.8, 7.8, 1.5, Ar H), 7.05 (1H, ddd,
J = 7.6, 7.6, 0.9, Ar H), 6.89 (1H, d, J = 8.1, Ar H); δC (125 MHz; DMSO-d6) 151.0 (s), 148.1 (s), 145.8 (s),
138.3 (s), 133.9 (s), 130.6 (d), 128.5 (d), 125.7 (d), 115.2 (d); m/z (EI) 237 (M+, 100%), 202 (M+-Cl, 5),
176 (M+-CClN, 9), 144 (M+-CClNS, 11), 118 (5), 93 (CClNS+, 11), 64 (6), identical to an authentic sample.
3.6.2. Synthesis of 4-Chloro-10H-[1,2,6]thiadiazino[3,4-b]quinoxaline (19)
Similar treatment of tetrachlorothiadiazine 1 (238 mg, 1.00 mmol) with benzene-1,2-diamine
(432 mg, 3.00 mmol) gave, after the solvent was evaporated in vacuo and the crude product precipitated
from EtOH (2 mL), the title compound 19 (160 mg, 68%) as purple needles, mp 310 °C (from EtOH, lit. [16]
310 °C subl.); Rf 0.17 (n-hexane/DCM, 50:50); νmax/cm−1 3237w, 3188w, 3140w, 3069w and 3051w (Ar
CH), 1605s, 1570w, 1514m, 1470m, 1414m, 1379s, 1275m, 1221m, 1115m, 957m, 924s, 878m, 800s,
766s, 741s; δH (500 MHz; DMSO-d6) 10.19 (1H, s, NH), 6.93 (1H, ddd, J = 7.8, 7.8, 1.1, Ar H), 6.87
(1H, d, J = 8.2, Ar H), 6.66 (1H, ddd, J = 7.9, 7.9, 0.8, Ar H), 6.38 (1H, d, J = 7.9, Ar H); δC (125 MHz;
DMSO-d6) 149.9 (s), 142.2 (s), 139.7 (s), 136.4 (s), 135.8 (s), 130.5 (d), 128.3 (d), 123.1 (d), 113.5 (d);
m/z (EI) 236 (M+, 100%), 201 (M+-Cl, 32), 174 (M+-CHClN, 8), 168 (7), 162 (4), 154 (6), 149 (6), 143
(M+-CClNS, 21), 131 (6), 118 (6), 102 (5), 90 (9), 76 (C6H4+,4), 69 (11), identical to the an authentic sample.
3.6.3. Synthesis of 4-Chloro-10-phenyl-10H-[1,2,6][3,4-b]quinoxaline (22)
Similar treatment of tetrachlorothiadiazine 1 (238 mg, 1.00 mmol) with N′-phenylbenzene-1,2-diamine
(368 mg, 2.00 mmol) gave after chromatography (DCM) the title compound 22 (212 mg, 68%) as brown
needles, mp 256–258 °C (from PhMe); Rf 0.81 (DCM); (found: C, 57.26; H, 2.54; N, 17.62. C15H9ClN4S
requires C, 57.60; H, 2.90; N, 17.91%); λmax (DCM)/nm 267 (log ε 4.37), 285 inf (4.29), 296 inf (4.24),
326 (4.14), 367 (3.94), 387 (3.98), 409 (3.83), 527 (3.68), 552 (3.69), 596 inf (3.44); νmax/cm−1 3048w,
1593m, 1504m, 1497m, 1485m, 1450m, 1360s, 1317m, 1173w, 1157m, 941m, 932m, 876m, 764s, 750s,
731s, 714s; δH (500 MHz; DMSO-d6) 7.58 (2H, dd, J = 7.4, 7.4, Ar H), 7.47 (1H, dd, J = 7.3, 7.3, Ar H),
7.33 (2H, d, J = 7.4, Ar H), 7.06 (1H, d, J = 7.5, Ar H), 6.87 (1H, dd, J = 7.4, 7.4, Ar H), 6.79 (1H, dd,
J = 7.4, 7.4, Ar H), 5.66 (1H, d, J = 7.9, Ar H); δC (125 MHz; DMSO-d6) 149.6 (s), 143.3 (s), 139.3 (s),
138.4 (s), 135.7 (s), 135.2 (s), 130.6 (d), 130.3 (d), 129.0 (d), 128.8 (d), 128.7 (d), 123.7 (d), 113.5 (d);
m/z (MALDI-TOF) 314 (M++2, 47%), 312 (M+, 95), 277 (M+-Cl, 100), 245 (M+-ClS, 36).